News | February 23, 2024
Moderna posts Q4 2023 revenue at US$ 2.8 billion
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
We are achieving the target of developed India by making our young children healthy today
The project aims at screening the general health condition of the students enrolled in classes 6th to 12th.
The preventive and promotive approach of our traditional health care systems has played a significant role in modern age today
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Minzoya Tablets are indicated for use by females of reproductive potential to prevent pregnancy
he lower sales in the current quarter are mainly on account of a one?time impact on the company’s India business
The company's SaaS solutions are tailored to enhance accessibility, efficiency, and patient-centricity in healthcare operations
Launches collaborative centre for translational research in head and neck cancer
Subscribe To Our Newsletter & Stay Updated
